It is also possible that residual GA-loaded nanoparticles may accumulate around tumor vessels and be absorbed more efficiently by TAFs, which regulate the secretion of Wnt16, an essential damage response program (DRP) molecule, around tumor vessels. The gene discussed is WNT16; the disease is neoplasm.